View Item 

Show simple item record

Mu and Delta opioid receptors activate the same G proteins in human neuroblastoma SH-SY5Y cells
dc.contributor.authorAlt, A.en_US
dc.contributor.authorClark, M. J.en_US
dc.contributor.authorWoods, James H.en_US
dc.contributor.authorTraynor, John R.en_US
dc.date.accessioned2010-06-01T19:03:46Z
dc.date.available2010-06-01T19:03:46Z
dc.date.issued2002-01en_US
dc.identifier.citationAlt, A; Clark, M J; Woods, J H; Traynor, J R (2002). "Mu and Delta opioid receptors activate the same G proteins in human neuroblastoma SH-SY5Y cells." British Journal of Pharmacology 135(1): 217-225. <http://hdl.handle.net/2027.42/72251>en_US
dc.identifier.issn0007-1188en_US
dc.identifier.issn1476-5381en_US
dc.identifier.urihttps://hdl.handle.net/2027.42/72251
dc.identifier.urihttp://www.ncbi.nlm.nih.gov/sites/entrez?cmd=retrieve&db=pubmed&list_uids=11786497&dopt=citationen_US
dc.format.extent216049 bytes
dc.format.extent3109 bytes
dc.format.mimetypeapplication/pdf
dc.format.mimetypetext/plain
dc.publisherBlackwell Publishing Ltden_US
dc.rights2002 British Pharmacological Societyen_US
dc.subject.otherMu-opioid Receptoren_US
dc.subject.otherDelta-opioid Receptoren_US
dc.subject.otherG Proteinen_US
dc.subject.other[ 35 S]-GTPΓS Bindingen_US
dc.subject.other[ 35 S]-GTPΓS Dissociationen_US
dc.subject.otherDAMGOen_US
dc.subject.otherSNC80en_US
dc.subject.otherCross-talken_US
dc.subject.otherSH-SY5Y Cellen_US
dc.titleMu and Delta opioid receptors activate the same G proteins in human neuroblastoma SH-SY5Y cellsen_US
dc.typeArticleen_US
dc.subject.hlbsecondlevelPharmacy and Pharmacologyen_US
dc.subject.hlbtoplevelHealth Sciencesen_US
dc.description.peerreviewedPeer Revieweden_US
dc.contributor.affiliationumDepartment of Psychology, University of Michigan, Ann Arbor, Michigan, U.S.A.en_US
dc.identifier.pmid11786497en_US
dc.description.bitstreamurlhttp://deepblue.lib.umich.edu/bitstream/2027.42/72251/1/sj.bjp.0704430.pdf
dc.identifier.doi10.1038/sj.bjp.0704430en_US
dc.identifier.sourceBritish Journal of Pharmacologyen_US
dc.identifier.citedreferenceABDELHAMID, E.E., SULTANA, M., PORTOGHESE, P.S. & TAKEMORI, A.E. ( 1991 ). Selective blockage of delta opioid receptors prevents the development of morphine tolerance and dependence in mice. J. Pharmacol. Exp. Ther., 258, 299 – 303.en_US
dc.identifier.citedreferenceBAUMHAKER, Y., GAFNI, M., KEREN, O. & SARNE, Y. ( 1993 ). Selective and interactive down-regulation of Μ- and Δ- opioid receptors in human neuroblastoma SK-N-SH cells. Mol. Pharmacol., 44, 461 – 467.en_US
dc.identifier.citedreferenceBERTIN, B., FREISSMUTH, M., JOCKERS, R., STROSBERG, A.D. & MARULLO, S. ( 1994 ). Cellular signaling by an agonist-activated receptor/GsΑ fusion protein. Proc. Natl. Acad. Sci. U.S.A., 91, 8827 – 8831.en_US
dc.identifier.citedreferenceBRADFORD, M.M. ( 1976 ). A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principal of protein-dye binding. Anal. Biochem., 72, 248 – 254.en_US
dc.identifier.citedreferenceBREIVOGEL, C.S., SELLEY, D.E. & CHILDERS, S.R. ( 1998 ). Cannabinoid receptor agonist efficacy for stimulating [ 35 S]GTPΓS binding to rat cerebellar membranes correlates with agonist-induced decreases in GDP affinity. J. Biol. Chem., 273, 16865 – 16873.en_US
dc.identifier.citedreferenceCHAKRABARTI, S., PRATHER, P.L., YU, L., LAW, P.Y. & LOH, H.H. ( 1995 ). Expression of mu-opioid receptor in CHO cells: ability of mu-ligands to promote Α-azidoanilide[ 32 P]GTP labeling of multiple G protein subunits. J. Neurochem., 64, 2534 – 2543.en_US
dc.identifier.citedreferenceCONKLIN, B.R., FARFEL, Z., LUSTIG, K.D., JULIUS, D. & BOURNE, H.R. ( 1993 ). Substitution of three amino acids switches receptor specificity of Gq alpha to that of Gi alpha. Nature, 363, 274 – 276.en_US
dc.identifier.citedreferenceCONNOR, M. & HENDERSON, G. ( 1996 ). Δ- and Μ-opioid receptor mobilization of intracellular calcium in SH-SY5Y human neuroblastoma cells. Br.J. Pharmacol., 117, 333 – 340.en_US
dc.identifier.citedreferenceCVEJIC, S. & DEVI, L.A. ( 1997 ). Dimerization of the Δ opioid receptor: implication for a role in receptor internalization. J. Biol. Chem., 272, 26959 – 26964.en_US
dc.identifier.citedreferenceELLIOTT, J., GUO, L. & TRAYNOR, J.R. ( 1997 ). Tolerance to Μ-opioid agonists in human neuroblastoma SH-SY5Y cells as determined by changes in guanosine-5′-O-(3-[ 35 S]-thio)triphosphate binding. Br. J. Pharmacol., 121, 1422 – 1428.en_US
dc.identifier.citedreferenceELLIOTT, J. & TRAYNOR, J.R. ( 1995 ). Evidence for lack of modulation of Μ-opioid agonist action by Δ-opioid agonists in the mouse vas deferens and guinea-pig ileum. Br. J. Pharmacol., 114, 1064 – 1068.en_US
dc.identifier.citedreferenceGEORGE, S.R., FAN, T., XIE, T., TSE, R., TAM, V., VARGHESE, G. & O'DOWD, B.F. ( 2000 ). Oligomerization of Μ and Δ opioid receptors: generation of novel functional properties. J. Biol. Chem., 275, 26128 – 26135.en_US
dc.identifier.citedreferenceGOMES, I., JORDAN, B.B., GUPTA, A., TRAPAIDZE, N., NAGY, V. & DEVI, L.A. ( 2000 ). Heterodimerization of Μ and opioid receptors: A role in opiate synergy. J Neurosci., 20, RC110 (1–5).en_US
dc.identifier.citedreferenceHEPBURN, M.J., LITTLE, P.J., GINGRAS, J. & KUHN, C.M. ( 1997 ). Differential effects of naltrindole on morphine-induced tolerance and physical dependence in rats. J. Pharmacol. Exp. Ther., 281, 1350 – 1356.en_US
dc.identifier.citedreferenceHEYMAN, J.S., JIANG, Q., ROTHMAN, R.B., MOSBERG, H.I. & PORRECA, F. ( 1989a ). Modulation of mu-mediated antinociception by delta agonists: characterization with antagonists. Eur. J. Pharmacol., 169, 43 – 52.en_US
dc.identifier.citedreferenceHEYMAN, J.S., VAUGHT, J.L., MOSBERG, H.I., HAASETH, R.C. & PORRECA, F. ( 1989b ). Modulation of mu-mediated antinociception by delta agonists in the mouse: selective potentiation of morphine and normorphine by [D-Pen 2, D-Pen 5 ]enkephalin. Eur. J., Pharmacol., 165, 1 – 10.en_US
dc.identifier.citedreferenceHIGASHIJIMA, T., FERGUSON, K.M., STERNWEIS, P.C., SMIGEL, M.D. and, GILMAN, A.G. ( 1987 ). Effects of Mg 2+ and the ΒΓ-subunit complex on the interactions of guanine nucleotides with G proteins. J. Biol. Chem., 262, 762 – 766.en_US
dc.identifier.citedreferenceHILF, G., KUPPRION, C., WIELAND, T. & JAKOBS, K.H. ( 1992 ). Dissociation of guanosine 5′-[Γ-thio]triphosphate from guanine-nucleotide-binding regulatory proteins in native cardiac membranes. Eur. J. Biochem., 204, 725 – 731.en_US
dc.identifier.citedreferenceHUANG, C., DUNCAN, J.A., GILMAN, A.G. & MUMBY, S.M. ( 1999 ). Persistent membrane association of activated and depalmitoylated G protein Α subunits. Proc. Natl. Acad. Sci. U.S.A., 96, 412 – 417.en_US
dc.identifier.citedreferenceJI, R.R., ZHANG, Q., LAW, P.Y., LOH, H.H., ELDE, R. & HOKFELT, T. ( 1995 ). Expression of Μ- Δ- and Κ-opioid receptor-like immunoreactivities in rat dorsal root ganglia after carrageenan-induced inflammation. J. Neurosci., 15, 8156 – 8166.en_US
dc.identifier.citedreferenceJIANG, Q., MOSBERG, H.I. & PORRECA, F. ( 1990 ). Modulation of the potency and efficacy of mu-mediated antinociception by delta agonists in the mouse. J. Pharmacol. Exp. Ther., 254, 683 – 689.en_US
dc.identifier.citedreferenceJORDAN, B.A. & DEVI, L.A. ( 1999 ). G-protein-coupled receptor heterodimerization modulates receptor function. Nature, 399, 697 – 700.en_US
dc.identifier.citedreferenceKAZMI, S.M.I. & MISHRA, R.K. ( 1987 ). Comparative pharmacological properties and functional coupling of Μ and Δ opioid receptor sites in human neuroblastoma SH-SY5Y cells. Mol. Pharmacol., 32, 109 – 118.en_US
dc.identifier.citedreferenceKENAKIN, T.P. & MORGAN, P.H. ( 1989 ). Theoretical effects of single and multiple transducer receptor coupling proteins on estimates of the relative potency of agonists. Mol. Pharmacol., 35, 214 – 222.en_US
dc.identifier.citedreferenceKEST, B., LEE, C.E., MCLEMORE, G.L. & INTURRISI, C.E. ( 1996 ). An antisense oligodeoxynucleotide to the delta opioid receptor (DOR-1) inhibits morphine tolerance and acute dependence in mice. Brain Research Bull., 39, 185 – 188.en_US
dc.identifier.citedreferenceLAUGWITZ, K.-L., OFFERMANS, S., SPICHER, K. & SCHULTZ, G. ( 1993 ). Μ and Δ opioid receptors differentially couple to G protein subtypes in membranes of human neuroblastoma SH-SY5Y cells. Neuron, 10, 233 – 242.en_US
dc.identifier.citedreferenceLEE, K.O., AKIL, H., WOODS, J.H. & TRAYNOR, J.R. ( 1999 ). Differential binding properties of oripavines at cloned Μ- and Δ-opioid receptors. Eur. J. Pharmacol., 278, 323 – 330.en_US
dc.identifier.citedreferenceMARTIN, N.A. & PRATHER, P.L. ( 2001 ). Interaction of co-expressed Μ- and Δ-opioid receptors in transfected rat pituitary GH 3 cells. Mol. Pharmacol., 59, 774 – 783.en_US
dc.identifier.citedreferenceMATTHES, H.W., SMADJA, C., VALVERDE, O., VONESCH, J.L., FOUTZ, A.S., BOUDINOT, E., DENAVIT-SAUBIE, M., SEVERINI, C., NEGRI, L., ROQUES, B.P., MOLDONADO, R. & KEIFFER, B.L. ( 1998 ). Activity of the Δ-opioid receptor is partially reduced, whereas activity of the Κ-receptor is maintained in mice lacking the Μ-receptor. J. Neurosci., 18, 7285 – 7295.en_US
dc.identifier.citedreferenceMILLIGAN, G. ( 2000 ). Insights into ligand pharmacology using receptor-G protein fusion proteins. Trends Pharmacol. Sci., 21, 24 – 28.en_US
dc.identifier.citedreferenceMURAYAMA, T. & UI, M. ( 1984 ). [ 3 H]GDP release from rat and hamster adipocyte membranes independently linked to receptors involved in activation or inhibition of adenylate cyclase. J. Biol. Chem., 259, 761 – 769.en_US
dc.identifier.citedreferencePELTON, J.T., KAZMIERSKI, W., GULYA, K., YAMAMURA, H.I. & HRUBY, V.J. ( 1986 ). Design and synthesis of conformationally constrained somatostatin analogues with high potency and specificity for mu opioid receptors. J. Med. Chem., 29, 2370 – 2375.en_US
dc.identifier.citedreferencePIKE, L.J. & LEFKOWITZ, R.J. ( 1981 ). Correlation of Β-adrenergic receptor-stimulated [ 3 H]GDP release and adenylate cyclase activation. J. Biol. Chem., 256, 2207 – 2212.en_US
dc.identifier.citedreferencePRATHER, P.L., LOH, H.H. & LAW, P.Y. ( 1994a ). Interaction of delta-opioid receptors with multiple G proteins: a non-relationship between agonist potency to inhibit adenylyl cyclase and to activate G proteins. Mol. Pharmacol., 45, 997 – 1003.en_US
dc.identifier.citedreferencePRATHER, P.L., TSAI, A.W. & LAW, P.Y. ( 1994b ). Mu and delta opioid receptor desensitization in undifferentiated human neuroblastoma SH-SY5Y cells. J. Pharmacol. Exp. Ther., 270, 177 – 184.en_US
dc.identifier.citedreferenceREMMERS, A.E., CLARK, M.J., ALT, A., MEDZIHRADSKY, F., WOODS, J.H. & TRAYNOR, J.R. ( 2000 ). Activation of G protein by opioid receptors: role of receptor number and G protein concentration. Eur. J. Pharmacol., 396, 67 – 75.en_US
dc.identifier.citedreferenceSCHILLER, P.W., WELTROWSKA, G., NGUYEN, T.M.D., WILKES, B.C., CHUNG, N.N. & LEMIEUX, C. ( 1993 ). TIPP[Ψ]: a highly potent and stable pseudopeptide Δ opioid receptor antagonist with extraordinary Δ selectivity. J. Med. Chem., 36, 3182 – 3187.en_US
dc.identifier.citedreferenceSHAPIRO, M., VOGEL, Z. & SARNE, Y. ( 2000 ). Opioid and cannabinoid receptors share a common pool of GTP-binding proteins in cotransfected cells, but not in cells which endogenously coexpress the receptors. Cell Mol. Neurobiol., 20, 291 – 304.en_US
dc.identifier.citedreferenceSHELDON, R.J., NUNAN, L. & PORRECA, F. ( 1989 ). Differential modulation by [D-Pen 2, D-Pen 5 ]enkephalin and dynorphin A-(1-17) of the inhibitory bladder motility effects of selected mu agonists in vivo. J. Pharmacol. Exp. Ther., 249, 462 – 469.en_US
dc.identifier.citedreferenceSTERNWEIS, P.C. & ROBISHAW, J.D. ( 1984 ). Isolation of two proteins with high affinity for guanine nucleotides from membranes of bovine brain. J. Biol. Chem., 259, 13806 – 13813.en_US
dc.identifier.citedreferenceTOSELLI, M., TOSETTI, P. & TAGLIETTI, V. ( 1997 ). Μ and Δ opioid receptor activation inhibits Ω-conotoxin-sensitive calcium channels in a voltage- and time-dependent mode in the human neuroblastoma cell line SH-SY5Y. Pflugers Arch-Eur. J. Physiol., 433, 587 – 596.en_US
dc.identifier.citedreferenceTRAYNOR, J.R. & ELLIOTT, J. ( 1993 ). Δ-Opioid receptor subtypes and cross-talk with Μ-receptors. Trends Pharmacol. Sci., 14, 84 – 86.en_US
dc.identifier.citedreferenceTRAYNOR, J.R. & NAHORSKI, S.R. ( 1995 ). Modulation by Μ-opioid agonists of guanosine-5′-O-(3-[ 35 S]thio)triphosphate binding to membranes from human neuroblastoma SH-SY5Y cells. Mol. Pharmacol., 47, 848 – 854.en_US
dc.identifier.citedreferenceUHL, G.R., CHILDERS, S.R. & PASTERNAK, G.W. ( 1993 ). An opiate-receptor gene family reunion. Trends Pharmacol. Sci., 17, 848 – 854.en_US
dc.identifier.citedreferenceVAUGHT, J.L., ROTHMAN, R.B. & WESTFALL, T.C. ( 1982 ). Mu and delta receptors: their role in analgesia and in the differential effects of opioid peptides on analgesia. Life Sci., 30, 1443 – 1455.en_US
dc.identifier.citedreferenceVAUGHT, J.L. & TAKEMORI, A.E. ( 1979 ). Differential effects of leucine -enkephalin and methionine enkephalin on morphine-induced analgesia, acute tolerance and dependence. J. Pharmacol. Exp. Ther., 208, 86 – 90.en_US
dc.identifier.citedreferenceZADINA, J.E., HARRISON, L.M., GE, L.-J., KASTIN, A.J. & CHANG, S.L. ( 1994 ). Differential regulation of Μ and delta opiate receptors by morphine, selective agonists and antagonists and differentiating agents in SH-SY5Y human neuroblastoma cells. J. Pharmacol. Exp. Ther., 270, 1086 – 1096.en_US
dc.identifier.citedreferenceZHU, Y., KING, M.A., SCHULLER, A.G.P., NITSCHE, J.F., REIDL, M., ELDE, R.P., UNTERWALD, E., PASTERNAK, G.W. & PINTAR, J.E. ( 1999 ). Retention of supraspinal delta-like analgesia and loss of morphine tolerance in Δ opioid receptor knockout mice. Neuron, 24, 243 – 252.en_US
dc.owningcollnameInterdisciplinary and Peer-Reviewed


Files in this item

Name:
sj.bjp.0704430.pdf
Size:
210.9KB
Format:
PDF
View/Open

Show simple item record

Remediation of Harmful Language

The University of Michigan Library aims to describe its collections in a way that respects the people and communities who create, use, and are represented in them. We encourage you to Contact Us anonymously if you encounter harmful or problematic language in catalog records or finding aids. More information about our policies and practices is available at Remediation of Harmful Language.

Accessibility

If you are unable to use this file in its current format, please select the Contact Us link and we can modify it to make it more accessible to you.